B.Sc,B.Pharma Graduates Walk In 14th Sept 2022 At Cipla Ltd

B.Sc,B.Pharma Graduates Walk In 14th Sept 2022 At Cipla Ltd. Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression and many other medical conditions.

Cipla Ltd invites Experienced, Dynamic & Self-Motivated Professionals  for the below positions at the Chennai location. 

Cipla Ltd is recruiting for the accompanying positions:

-Therapy Manager

-Hospital Business Manager 

-Scientific Business Manager

-Antibiotics

-Injectables - Critical care

Refer Notification & all relevant information below. Interested and qualified applicants can attend at scheduled time.

Opportunity subtleties:

Post Name: Therapy Manager/Hospital Business Manager/Scientific Business Manager/ Antibiotics/Injectables - Critical care

Capability: B.Sc , Any Graduate, B.Pharma

Experienced:02 to 7 years

Set of working responsibilities: Cipla Ltd Hiring For Therapy Manager/Hospital Business Manager/Scientific Business Manager/ Antibiotics/Injectables - Critical care !

Significant Details :

Place: Chennai

Walk in Interview Date: 14th Sept 2022

Time: 10.00 AM - 6.00 PM

Walk In Address:- Cipla Ltd, 06-A, Alapakkam main road, near Porur, Alapakkam, Chennai - 600116

Contact - Gayathiri N 

Note:If Intrested can send your CV at hrhubsouth@cipla.com

Choice Process: The determination will be based on Interview.

Set of working responsibilities:

Therapy Manager - age less than 29 yrs. / Hospital Business Manager/Scientific Business Manager - age less than 34 yrs.

Therapy Manager: Antibiotics/Injectables - Critical care.

HBM/SBM - Key Account Management/Rheumatology/Institutional Sales

Eligibility Criteria:

- only Female candidates

- Not looking for freshers

- Preference to Science Graduates

- Relevant experience in pharmaceutical sales

- Good communication skills

- Worked for less than 4 companies

Post a Comment

0 Comments